Christopher M. Scull, PhD

Christopher M. Scull, PhD

Senior Consultant

Christopher Scull, PhD, is a drug development professional whose experience has spanned research, discovery, preclinical development, and regulatory affairs.  Dr. Scull’s expertise includes product development strategy, design and management of pharmacology and toxicology studies, writing and reviewing FDA submissions, and achieving GLP compliance.

Prior to joining Biologics Consulting, Chris served as Global Director, Discovery Sciences, at Innovimmune Biotherapeutics, where he managed development of a portfolio of pre-IND drug candidates.  In addition to being the site-head for the Brooklyn-based research team, Chris was responsible for preclinical development planning and management of nonclinical studies.

Dr. Scull also served in multiple roles at Memorial Sloan Kettering Cancer Center (MSKCC).  As a member of the Investigational Products team, he co-authored and reviewed IND applications and assisted investigators with FDA compliance during the design and conduct of pharmacology and toxicology studies.  In a subsequent role at MSKCC, Chris led the establishment of a new testing facility for GLP-compliant nonclinical studies which included the design of laboratory and animal facilities, installation and validation of new equipment, authoring of SOPs, and training of personnel for GLP compliance.

While completing his doctoral studies at the University of North Carolina at Chapel Hill, Chris assisted the biotech startup Entegrion with preparation and analysis of test articles for nonclinical studies and pre-approval testing of a new trauma bandage.


Chris received his BS in Chemistry from UNC Chapel Hill in 2003 and his PhD in Cellular and Molecular Pathology from UNC Chapel Hill in 2009.  He is also PMP certified by the Project Management Institute and holds the Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society.  Chris joined Biologics Consulting in 2017 and currently resides with his family in Silver Spring, Maryland.